The Role of Adaptive and Innovative Trial Designs in Diabetes Research: A Scoping Review

Adaptive and master protocol trials remain rare in diabetes. Overcoming barriers through targeted training and awareness, robust regulatory frameworks, and strategic incentives could support broader adoption.

Authors

Institutions

Publication Details

Journal
Diabetes Care
Published
2025-11-20
DOI
https://doi.org/10.2337/dc25-1508
Primary Topic
Statistical Methods in Clinical Trials
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Role of Adaptive and Innovative Trial Designs in Diabetes Research: A Scoping Review

Elizabeth Holmes‐Truscott, Elif Ilhan Ekinci, Leonid P. Churilov, Michele Gaca et al.
Diabetes Care
Statistical Methods in Clinical Trials
article

The Role of Adaptive and Innovative Trial Designs in Diabetes Research: A Scoping Review

Elizabeth Holmes‐Truscott, Elif Ilhan Ekinci, Leonid P. Churilov, Michele Gaca, Negar Naderpoor, Rury R. Holman, David Norman O'Neal, Andrew A. Farmer, Christine Somerville, Kamlesh K. Khunti, Rose Lin, Ashni Goshrani
article en

Abstract

Adaptive and master protocol trials remain rare in diabetes. Overcoming barriers through targeted training and awareness, robust regulatory frameworks, and strategic incentives could support broader adoption.

Diabetes CareVol. 49(1)
The Royal Melbourne Hospital (AU), Australian Research Council (AU), Deakin University (AU), University of Leicester (GB), The University of Melbourne (AU), Diabetes Australia (AU), University of Oxford (GB), St Vincent's Hospital Melbourne (AU), Eastern Health (AU), Monash Health (AU), Oxford Centre for Diabetes, Endocrinology and Metabolism (GB), Austin Health (AU), NIHR Leicester Biomedical Research Centre (GB), Monash University (AU)
Amgen, Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Nestlé Health Science, Diabetes Canada, National Institute for Health and Care Research, British Heart Foundation, Diabetes Australia, Deakin University, Daiichi-Sankyo, Novo Nordisk, Servier, Diabetes Victoria, MTPConnect, Medical Research Council, National Health and Medical Research Council, NIHR Leicester Biomedical Research Centre
Openalex Percentile: Top 67%
Statistical Methods in Clinical Trials
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.